Cytokine Growth Factor Rev. 1998 Mar;9(1):37-48.

FLT3: receptor and ligand. Biology and potential clinical application.

Source

Department of Surgical Oncology and Biological Therapeutics Program, University of Pittsburgh Cancer Institute, PA 15213, USA. mshu@med.pitt.edu

Abstract

Flt3 ligand (FL) is a recently identified cytokine having a central role in the proliferation, survival and differentiation of early murine and human hematopoietic precursor/stem cells. FL acts synergistically in vitro with a number of other hematopoietic growth factors such as IL-3, IL-6, IL-11, IL-12, KIT Ligand and GM-CSF. Recently, it has been shown the in vivo administration of FL results in a significant alteration of hematopoiesis in murine bone marrow (BM), spleen, peripheral blood, liver and lymph nodes. In addition, treatment with FL resulted in a significant accumulation of functionally active dendritic cells within murine lymphoid tissues. The possible applications of FL in dendritic cell-based immunotherapies are discussed.

PMID:: 9720755; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Related citations

Review Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. [Leukemia. 1996]
Review Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG. Leukemia. 1996 Apr; 10(4):588-99.
Review Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis. [Stem Cells. 1996]
Review Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis.
Namikawa R, Muench MO, Roncarolo MG. Stem Cells. 1996 Jul; 14(4):388-95.
The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis. [Exp Hematol. 1996]
The effects of human FLT3 ligand on in vitro human megakaryocytopoiesis.
Piacibello W, Garetto L, Sanavio F, Severino A, Fubini L, Stacchini A, Dragonetti G, Aglietta M. Exp Hematol. 1996 Feb; 24(2):340-6.
Review The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor. [Stem Cells. 1994]
Review The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
Lyman SD, Brasel K, Rousseau AM, Williams DE. Stem Cells. 1994; 12 Suppl 1:99-107; discussion 108-10.
The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. [Blood. 1995]
The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors.
Hirayama F, Lyman SD, Clark SC, Ogawa M. Blood. 1995 Apr 1; 85(7):1762-8.

See reviews... See all...

Cited by 7 PubMed Central articles

High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation. [Haematologica. 2011]
High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation.
De Propris MS, Raponi S, Diverio D, Milani ML, Meloni G, Falini B, Foà R, Guarini A. Haematologica. 2011 Oct; 96(10):1548-51. Epub 2011 Jul 26.
Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent Manner. [Genes Cancer. 2010]
Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent Manner.
Jiang J, Griffin JD. Genes Cancer. 2010 Feb; 1(2):164-76.
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors. [Cancer Res. 2009]
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.
Curran MA, Allison JP. Cancer Res. 2009 Oct 1; 69(19):7747-55. Epub 2009 Sep 8.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

FLT3: receptor and ligand. Biology and potential clinical application.
FLT3: receptor and ligand. Biology and potential clinical application.
Cytokine Growth Factor Rev. 1998 Mar ;9(1):37-48.

PubMed
Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human h...
Regulatory roles of the ligand for Flk2/Flt3 tyrosine kinase receptor on human hematopoiesis.
Stem Cells. 1996 Jul ;14(4):388-95.

PubMed
Mothers in recovery: rebuilding families in the aftermath of addiction.
Mothers in recovery: rebuilding families in the aftermath of addiction.
Soc Work. 1996 Mar ;41(2):214-23.

PubMed
Phosphatidylinositol-3' kinase is not required for mitogenesis or internalizatio...
Phosphatidylinositol-3' kinase is not required for mitogenesis or internalization of the Flt3/Flk2 receptor tyrosine kinase.
J Biol Chem. 1996 Aug 16 ;271(33):20075-81.

PubMed
The molecular sociology of the cell.
The molecular sociology of the cell.
Nature. 2007 Dec 13 ;450(7172):973-82.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

FLT3: receptor and ligand. Biology and potential clinical application.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Cited by 7 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information